An Evaluation of MiniMed™ 780G System Performance in Childhood: A Single Center Experience from Turkey

被引：0
|
作者：
Eviz, Elif [1 ]
Mutlu, R. Gul Yesiltepe [1 ]
Can, Ecem [2 ]
Gokce, Tugba [2 ]
Muradoglu, Serra [2 ]
Hatun, Sukru [1 ]
机构：
[1] Koc Univ, Istanbul, Turkey
[2] Koc Univ Hosp, Istanbul, Turkey
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2022年 / 95卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1-50
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [31] MiniMed 780G Advanced Hybrid Closed Loop System Outcomes According to Pubertal Status - Awesome Study Group Real-Life Experience
    Rachmiel, Marianna
    Lebenthal, Yael
    Mazor-Aronovitch, Kineret Kineret
    Brener, Avivit
    Levek, Noah
    Polishuk-Yakobi, Talia
    Tal Ben, Tal
    Abiri, Shirli
    Landau, Zohar
    Pinhas-Hamiel, Orit
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 194 - 194
  • [32] GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS
    Tuomaala, A. -K.
    Varimo, T.
    Hakonen, E.
    Kiiveri, S.
    Janer, J.
    Hyvonen, M.
    Wehkalampi, K.
    Laakkonen, H.
    Laakso, S.
    Harsunen, M.
    Hero, M.
    Miettinen, P.
    Pulkkinen, M. -A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A82 - A82
  • [33] Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users
    Arrieta, Arcelia
    Battelino, Tadej
    Scaramuzza, Andrea E.
    Da Silva, Julien
    Castaneda, Javier
    Cordero, Toni L.
    Shin, John
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1370 - 1379
  • [34] MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience
    Rachmiel, Marianna
    Lebenthal, Yael
    Mazor-Aronovitch, Kineret
    Brener, Avivit
    Levek, Noah
    Jacobi-Polishook, Talia
    Ben Ari, Tal
    Abiri, Shirli
    Landau, Zohar
    Pinhas-Hamiel, Orit
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (09) : 643 - 651
  • [35] ADVANCED HYBRID CLOSED LOOP SYSTEM MINIMED 780G IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: DOES PREVIOUS PUMP EXPERIENCE IMPACT THE GLYCEMIC CONTROL?
    Petrovski, G.
    Campbell, J.
    Al Khalaf, F.
    Day, E.
    Pasha, M.
    Hussain, K.
    Khalifa, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A105 - A106
  • [36] Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
    Thrasher, James R.
    Arrieta, Arcelia
    Niu, Fang
    Cameron, Katherine R.
    Cordero, Toni L.
    Shin, John
    Rhinehart, Andrew S.
    Vigersky, Robert A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 : 24 - 31
  • [37] Comparison of Six Months Experience on Hybrid Closed Loop MiniMed 670G System and Advanced Hybrid Closed Loop MiniMed 780G System Using a Structured Initiation Protocol in Children and Adolescents with Type 1 Diabetes
    Petrovski, Goran
    Campbell, Judith
    Alkhalaf, Fawziya
    Hussain, Khalid
    DIABETES, 2022, 71
  • [38] Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system
    Grassi, Bruno
    Gomez, Ana Maria
    Calliari, Luis Eduardo
    Franco, Denise
    Raggio, Marcela
    Riera, Francisca
    Castro, Matias
    McVean, Jennifer
    van den Heuvel, Tim
    Arrieta, Arcelia
    Castaneda, Javier
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1688 - 1697
  • [39] MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias: Response to Inaccurate Allegations
    van den Heuvel, Tim
    Castaneda, Javier
    Thijs, Isabeau
    Arrieta, Arcelia
    Lintereur, Lou
    Shin, John
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024,
  • [40] SYSTEM MINIMED 780G PROVIDES SATISFACTORY GLUCOSE CONTROL IN ADOLESCENTS WITH TYPE 1 DIABETES DURING FOOTBALL SPORTS CAMP
    Gawrecki, A.
    Chrzanowski, J.
    Michalak, A.
    Fendler, W.
    Szadkowska, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A91 - A92
12345